Fintech ‘unicorn’ Numbrs slashes jobs as investors turn tail
Numbrs has a custom-made premises in Zurich to house its HQ.
All Rights Reserved
The mobile banking app Numbrs is poised to cut 62 of its Zurich-based staff after investors pulled out of an agreement to inject new funds into the company. Just last year, the fintech firm said it was worth CHF1 billion having attracted big ticket investments from around the world.
This content was published on
2 minutes
I write about the rapidly evolving artificial intelligence technology and its possible impacts on society.
Originally from England, I spent some time at the BBC in London before moving to Switzerland to join SWI swissinfo.ch.
The digital finance platform employs around 150 staff at its headquarters in Zurich. Operating mainly in the German market, Numbrs had raised $200 million (CHF195 million) in previous funding rounds despite failing to make an annual profit since its inception in 2014.
But the company now faces a painful restructuring period because “a new round of financing in the high double-digit million range has not materialized despite a legally binding signature”. The company did not name the proposed investors or say whether they had pulled out due to the economic uncertainties created by coronavirus.
As a result of the blow, Numbrs says it must now reduce fixed costs, such as staff wages, by 50%. But the company is going ahead with plans to enter the British market.
“I would like to ask all Numbrs employees for understanding that, like many other startups, we now have to prepare for a longer dry spell,” stated managing partner Fynn Kreuz.
The coronavirus pandemic has negatively impacted venture capital funding as the economy and financial markets have been thrown into turmoil. Several investors have seen their own wealth shrink and are concentrating on keeping their current portfolio of start-ups afloat rather than risking new investments.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
Situation in Swiss landslide valley remains unstable
This content was published on
Authorities in Valais said on Thursday that it was still too dangerous to begin clear-up activities around the village of Blatten.
Spar Switzerland put up for sale by South African owner
This content was published on
Talks with potential buyers of the 360-plus Spar stores in Switzerland are underway, but it’s not clear who’s in the running.
Further villages in Swiss landslide area avoid damage for now
This content was published on
Due to the build-up of a lake behind the debris in Blatten, canton Valais, parts of neighbouring villages have been evacuated as a precaution.
Glacier collapses burying large parts of Swiss village Blatten
This content was published on
A gigantic avalanche of ice, mud and debris has buried a large part of the village of Blatten after a major glacier collapsed.
Swiss government seeks better labour integration of Ukrainian refugees
This content was published on
The Swiss government has now set a goal of 50% of Ukrainian refugees to be in employment by the end of 2025, compared with 38% at present.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss fintech scene on the verge of a ‘big decade’
This content was published on
The number of financial technology start-ups is rapidly growing in Switzerland, as is the amount of funding they receive from venture capitalists.
Swiss venture capital funding breaks CHF2 billion barrier
This content was published on
New ventures in the ICT and fintech sectors received the largest slice of funding (CHF1.2 billion), but financial support for early stage biotech firms also received a significant boost (CHF625 million), according to the annual reportExternal link from online news portal startupticker.chExternal link and the investor association SECAExternal link. Four Swiss companies – ADC Therapeutics,…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.